Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3186studies shown
Showing 1,501-1,525 of 3,186
CompletedNCT02090634

Texting to Improve Adherence in HIV+ With Bipolarity

This study exists to see whether psychoeducation, a guided learning and support program, is workable and worth testing more broadly. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can better prevent setbacks and support longer-term stability.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Bipolarity
CompletedNCT02188732

Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes

This study exists to see whether smoking support or smoking-related treatment can play a useful role in care. Researchers are trying to understand whether smoking support or smoking-related treatment can better prevent setbacks and support longer-term stability.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Condition
Schizophrenia
CompletedNCT02082678

Ondansetron for Bipolarity and Alcohol Use Disorders

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Bipolarity
TerminatedNCT04251234

Light at Night Study

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

BipolarityOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
University of Michigan
Condition
Bipolarity
CompletedNCT04068467

Evaluation of mHealth for Serious Mental Illness

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. For people living with Schizophrenia, that matters because support often needs to fit around real routines and access barriers.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
University of Washington
Condition
Schizophrenia
CompletedNCT03730064

Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Depression in bipolarity

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

BipolarityOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Martin Lan
Condition
Bipolarity
CompletedNCT01976975

Brain Mechanisms of Human Motivation

This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand what questionnaires and follow-up reports can reveal about signals in the brain or body that may guide care later on.

DepressionOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Depression
TerminatedNCT02075047

Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolarity I

This study exists to explore whether the medication Flexible could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

BipolarityOtherFrom 10 Years to 17 Years
Countries
Ukraine, United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
TerminatedNCT03768726

Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolarity I

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

BipolarityOtherFrom 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
CompletedNCT02773420

HET Bipolar System: Validation of Outpatient Hemorrhoid Treatment

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
University of Illinois at Chicago
Condition
Bipolarity
CompletedNCT03822416

Treating Smokers With Mental Illness

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can give earlier or clearer feedback during care.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Depression
CompletedNCT02974010

Sequential Therapy for the Treatment of Severe Depression in bipolarity.

This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can better prevent setbacks and support longer-term stability.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
NeuroRx, Inc.
Condition
Bipolarity
CompletedNCT00666432

Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

BipolarityOtherOver 15 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Bipolarity
CompletedNCT01948024

Bio-equivalence Study Between SAPHRIS and Asenapine

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
United States
Sponsor
Sun Pharmaceutical Industries Limited
Condition
Schizophrenia
CompletedNCT00312494

3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects

This study exists to understand whether this type of care is both safe enough and useful enough to take further. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
CompletedNCT00282464

A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
CompletedNCT03050853

The Appeal and Impact of E-cigarettes in Smokers With SMI

This study exists to see whether smoking support or smoking-related treatment can make care clearer and more responsive. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Condition
Schizophrenia
CompletedNCT00141271

A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression

This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
CompletedNCT00265330

Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolarity I (Manic or Mixed)

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

BipolarityOtherFrom 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
CompletedNCT00280566

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolarity I (Manic or Mixed)

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

BipolarityOtherOver 18 Years
Countries
Chile, France, Germany, Guatemala, China, India, Italy, Mexico, Russian Federation, Spain, Taiwan, United States, Venezuela
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
TerminatedNCT00055575

Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression
CompletedNCT01431573

Wake Therapy in the Treatment of Depression

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.

DepressionOtherFrom 18 Years to 75 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Depression
CompletedNCT00483548

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

BipolarityOtherOver 18 Years
Countries
Australia, India, United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity